05/13/2026
Hunger was never a willpower problem. It was a signaling problem.
When you eat, your gut releases GLP-1, a hormone that travels directly to your brain to say you're full. When that signal is weak, the brain keeps asking for more. And it's not just hunger it affects. GLP-1 receptors live in the brain's reward system too — the circuitry governing craving, urgency, and why food feels impossible to ignore at the wrong moments. That's not a discipline failure. That's an incomplete signal.
After 40, estrogen decline disrupts GLP-1 signaling directly and drives insulin resistance on top of it. The hormonal architecture that was quietly managing your appetite and metabolism shifted. Not because you changed. Because your biology did.
GLP-1 receptor agonists restore that signal. Tirzepatide goes further — activating two receptors simultaneously, GLP-1 and GIP, addressing both the brain signaling and the insulin resistance driving visceral fat accumulation.
In the SURMOUNT-1 trial published in the New England Journal of Medicine, participants achieved average weight reductions of 16% at 5mg, 21.4% at 10mg, and 22.5% at 15mg.
The protocol that works is the one built around your actual biology. Not a generic starting point. Yours.
sosothin.com
Weight Loss and Wellness Delivered.
